(Reuters) – MBX Biosciences, which is developing peptide therapies for treating endocrine and metabolic disorders, including obesity, said on Monday it was seeking a valuation of up to $482.5 million in its initial public offering in the United States.WHY...
(In Aug 15 story, corrects typo in firm name in paragraph 10 to “+” from “&”)By Alden BentleyNEW YORK (Reuters) -U.S. Treasury yields surged on Thursday after strong economic data all but eliminated fears about a hard economic landing and...
(Reuters) – Shares of some mpox vaccine and drug developers jumped sharply on Monday in premarket trading, putting them on track to extend gains from last week as concerns over an outbreak of the virus rise.Shares of GeoVax Labs and Tonix Pharmaceuticals led the...
By Alden BentleyNEW YORK (Reuters) -U.S. Treasury yields eased on Friday, partly reversing the previous day’s big gains as investors digested data showing a resilient U.S. consumer and inflation trending lower, leaving the Federal Reserve ample scope for a small...
(Reuters) – Speculators raised their net short bets on five-year Treasuries to the largest on record in the latest week, while bearish bets on 10-year Treasury futures were the largest since January, according to data by the Commodity Futures Trading Commission...
(Reuters) -Investment firm Sixth Street will acquire Enstar for $5.1 billion, in a deal backed by former Treasury Secretary Steven Mnuchin and billionaire J Christopher Flowers, the insurer said on Monday.The deal will allow Sixth Street, an existing Enstar investor...
